Key Points
- Major shareholder Shih-Yao David Lin bought 39,937 IRIDEX shares at an average price of $1.00, increasing his direct ownership by 13.39% to 338,285 shares.
- IRIDEX reported weaker-than-expected quarterly results, with a loss of $0.07 per share versus the $0.01 consensus estimate and revenue of $12.57 million versus $13.59 million expected.
- The stock opened at $0.88 and remains highly volatile, with a market capitalization of about $15.46 million; analysts have a consensus “Hold” rating and an average price target of $3.00.
IRIDEX Corporation (NASDAQ:IRIX - Get Free Report) major shareholder Shih-Yao David Lin acquired 10,000 shares of the firm's stock in a transaction that occurred on Thursday, October 16th. The stock was purchased at an average cost of $1.05 per share, for a total transaction of $10,500.00. Following the completion of the purchase, the insider directly owned 735,561 shares of the company's stock, valued at $772,339.05. The trade was a 1.38% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
IRIDEX Price Performance
Shares of IRIX opened at $0.88 on Thursday. The firm has a 50 day simple moving average of $0.73 and a two-hundred day simple moving average of $0.95. IRIDEX Corporation has a one year low of $0.61 and a one year high of $1.65. The company has a market cap of $15.46 million, a P/E ratio of -4.40 and a beta of 0.67.
IRIDEX (NASDAQ:IRIX - Get Free Report) last issued its earnings results on Tuesday, August 18th. The medical equipment provider reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.06). The business had revenue of $12.57 million during the quarter, compared to analysts' expectations of $13.59 million. On average, analysts expect that IRIDEX Corporation will post -0.12 earnings per share for the current fiscal year.
Key Headlines Impacting IRIDEX
Here are the key news stories impacting IRIDEX this week:
- Positive Sentiment: SEC disclosures show Lin made dozens of purchases totaling substantial share amounts, including transactions of 50,000 shares at $0.99, 40,114 shares at $1.00 and 80,000 shares at $1.00. The repeated buying and growing ownership stake may be interpreted as a sign of confidence in IRIDEX’s long-term prospects. IRIDEX major shareholder buys 50,000 shares
- Positive Sentiment: The filings also include purchases at prices ranging from approximately $0.84 to $1.52, with several individual transactions valued between roughly $20,000 and $58,000. This broad pattern of buying, rather than a single isolated trade, likely attracted speculative interest in the thinly traded stock. IRIDEX major shareholder acquires stock
- Neutral Sentiment: Investors should note that most purchases occurred weeks or months earlier, from March through June and in prior reporting periods; the disclosures are new, but the buying itself is not. The reports therefore provide sentiment support rather than evidence of a new operating development or immediate improvement in revenue and earnings.
- Neutral Sentiment: Trading in IRIX was temporarily halted under a Limit Up-Limit Down (LULD) pause, indicating that the stock’s rapid move exceeded permitted price bands. This highlights significant volatility and the potential for sharp reversals once trading resumes.
Hedge Funds Weigh In On IRIDEX
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Perkins Capital Management Inc. boosted its position in IRIDEX by 33.9% in the first quarter. Perkins Capital Management Inc. now owns 55,300 shares of the medical equipment provider's stock valued at $56,000 after buying an additional 14,000 shares in the last quarter. Thompson Davis & CO. Inc. increased its holdings in shares of IRIDEX by 66.5% during the first quarter. Thompson Davis & CO. Inc. now owns 47,444 shares of the medical equipment provider's stock worth $48,000 after buying an additional 18,944 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of IRIDEX by 6.7% in the 1st quarter. Renaissance Technologies LLC now owns 396,627 shares of the medical equipment provider's stock valued at $401,000 after acquiring an additional 25,067 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of IRIDEX in the 2nd quarter valued at $29,000. Finally, Diversify Wealth Management LLC bought a new position in shares of IRIDEX in the 1st quarter valued at $35,000. Institutional investors own 20.10% of the company's stock.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised IRIDEX from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, October 2nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, IRIDEX presently has a consensus rating of "Hold" and a consensus target price of $3.00.
Check Out Our Latest Stock Report on IRIDEX
About IRIDEX
(
Get Free Report)
IRIDEX Corporation (NASDAQ: IRIX) develops and sells ophthalmic laser systems and related delivery devices used in the treatment of eye diseases. Its products are designed primarily for ophthalmologists treating glaucoma and retinal disorders, including diabetic retinopathy and other conditions affecting the retina.
The company's portfolio includes laser systems such as the Cyclo G6 glaucoma laser platform and the IQ series of retinal photocoagulation lasers. IRIDEX also offers specialized probes and other delivery devices, including MicroPulse and transscleral cyclophotocoagulation technologies, which are intended to provide targeted treatment while limiting exposure to surrounding tissue.
Founded in 1989 and headquartered in Mountain View, California, IRIDEX serves eye-care professionals through a combination of direct sales and distributor relationships in the United States and international markets.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
